Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010)

Journal of the American Veterinary Medical Association

Volumn 242, Issue 4, 2013, Pages 499-506

  Higuchi, Takashi ^a,b   Burcham, Grant N ^a   Childress, Michael O ^a   Rohleder, Jacob J ^a   Bonney, Patty L ^a   Ramos Vara, José A ^a   Knapp, Deborah W ^a  

^a PURDUE UNIVERSITY   (United States)

^b Japan Small Animal Cancer Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873245262     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.242.4.499     Document Type: Article

References (20)

1. Knapp DW. Tumors of the urinary system. In: Withrow SJ, Vail DM, eds. Withrow and MacEwen's small animal clinical oncology. 4th ed. St Louis: WB Saunders Co, 2007;649-658.
2. Gilson SD, Stone EA. Surgically induced tumor seeding in eight dogs and two cats. J Am Vet Med Assoc 1990;196:1811-1815.
3. Liptak JM, Brutscher SP, Monnet E, et al. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg 2004;33:505-516.
4. Nyland TG, Wallack ST, Wisner ER. Needle-tract implantation following us-guided fine-needle aspiration biopsy of transitional cell carcinoma of the bladder, urethra, and prostate. Vet Radiol Ultrasound 2002;43:50-53.
5. Ramos-Vara JA, Miller MA, Boucher M, et al. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Vet Pathol 2003;40:55-62.
6. Lai CL, van den Ham R, van Leenders G, et al. Histopathological and immunohistochemical characterization of canine prostate cancer. Prostate 2008;68:477-488.
7. Owens L. TNM classification of tumors in domestic animals. Geneva: World Health Organization, 1980;34.
8. Chun R, Knapp DW, Widmer WR, et al. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1997;11:279-283.
9. McMillan SK, Boria P, Moore GE, et al. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 2011;239:1084-1089.
10. Wilting J, Papoutsi M, Christ B, et al. The transcription factorProx1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002;16:1271-1273.
11. Martin A, Gasse H, Staszyk C. Absence of lymphatic vessels in the dog dental pulp: an immunohistochemical study. J Anat 2010;217:609-615.
12. Via KJ, Burns KM, Lamm DL. Tumor implantation: a rare but potentially preventable cause of death in cystectomy patients. Can J Urol 2010;17:5216-5218.
13. Huang J, Lin T, Liu H, et al. Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer: oncologic results of 171 cases with a median 3-year follow-up. Eur Urol 2010;58:442-449.
14. Rouprêt M, Smyth G, Irani J, et al. Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol 2009;27:81-88.
15. Chakavarti A, Day DW, MacDermott S. Extravesical transitional cell carcinoma as a result of implantation after perforation of the bladder. BJU Int 2000;85:1150-1151.
16. Abaza R, Miocinovic R, Keck RW, et al. Prevention and treatment of transitional cell carcinomatosis with intraperitoneal chemotherapy in a rat model. J Urol 2009;181:1901-1906.
17. Tsivian A, Sidi AA. Port site metastases in urological laparoscopic surgery. J Urol 2003;169:1213-1218.
18. Anderson WI, Dunham BM, King JM, et al. Presumptive subcutaneous surgical transplantation of a urinary bladder transitional cell carcinoma in a dog. Cornell Vet 1989;79:263-266.
19. Evans HE, Christensen GC. The urogenital system. In: Evans HE, ed. Miller's anatomy of the dog. 3rd ed. Philadelphia: WB Saunders Co, 1993;494-558.
20. Knapp DW, Adams LG, Degrand AM, et al. Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 2007;52:1700-1708.